Hiroshi Tazawa

Associate Professor

Okayama University Hospital

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hiroshi Tazawa is an Associate Professor at Okayama University Hospital in Japan. His research focuses on oncolytic virotherapy, immunogenic cell death, and cancer therapies, as highlighted in his recent articles. He explores innovative approaches for cancer treatment, including p53-armed virotherapy and the use of exosomes for drug delivery. His work contributes significantly to understanding the mechanisms of cancer cell resistance and therapeutic efficacy.

Articles (14)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Satoru Kikuchi

Assistant Professor

Okayama Daigaku

JAPAN

View details

Akihiro Matsukawa

Okayama University

JAPAN

View details

Tomohiro Fujiwara

Assistant Professor

Okayama University Hospital

JAPAN

View details

Hajime Kashima

Okayama University Hospital

JAPAN

View details

Hiroya Kondo

Okayama University Hospital

JAPAN

View details

Toshiyoshi Fujiwara

JAPAN

View details

Joe Hasei

Professor

Okayama University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hiroshi Tazawa

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

p53-armed oncolytic virotherapy induces abscopal effect in osteosarcoma by promoting immunogenic cell death

Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus

Conventional Cancer Therapies Can Accelerate Malignant Potential of Cancer Cells by Activating Cancer-Associated Fibroblasts in Esophageal Cancer Models

p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells

Exosomes as a drug delivery tool for cancer therapy: a new era for existing drugs and oncolytic viruses

Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer

Tumor‐targeted fluorescence labeling systems for cancer diagnosis and treatment

Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression

Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer

Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells

Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model

Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma

Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression

Role of Tumor-Associated Macrophages in Sarcomas

Collaborators (7)

Satoru Kikuchi

Akihiro Matsukawa

Tomohiro Fujiwara

Hajime Kashima

Hiroya Kondo

Toshiyoshi Fujiwara

Joe Hasei

Make your next move.